What are the diagnostic criteria for type 1 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Type 1 Diabetes

Type 1 diabetes is diagnosed when a patient has hyperglycemia meeting the criteria for 'diabetic type' on two separate occasions, or on a single occasion if accompanied by classic symptoms, HbA1c ≥6.5%, or diabetic retinopathy. 1

General Diagnostic Criteria for Diabetes

The following criteria can be used to diagnose diabetes (including type 1):

  • Fasting plasma glucose (FPG) ≥126 mg/dL (7.0 mmol/L) - fasting defined as no caloric intake for at least 8 hours 1
  • 2-hour plasma glucose (2-h PG) ≥200 mg/dL (11.1 mmol/L) during an oral glucose tolerance test (OGTT) 1
  • HbA1c ≥6.5% (48 mmol/mol) - test should be performed in a laboratory using NGSP certified method 1
  • Random plasma glucose ≥200 mg/dL (11.1 mmol/L) in a patient with classic symptoms of hyperglycemia or hyperglycemic crisis 1

In the absence of unequivocal hyperglycemia, the first three criteria should be confirmed by repeat testing 1.

Specific Criteria for Type 1 Diabetes

Type 1 diabetes is distinguished from other types by:

  • Presence of one or more islet autoantibodies 1, 2
  • Primary autoantibody measured should be glutamic acid decarboxylase (GAD) 2
  • If GAD negative, testing for islet tyrosine phosphatase 2 (IA-2) and/or zinc transporter 8 (ZnT8) antibodies should follow 2
  • In individuals not treated with insulin, antibodies against insulin (IAA) may also be useful 2

Staging of Type 1 Diabetes

Type 1 diabetes develops in three distinct stages 1:

Stage 1

  • Presence of two or more islet autoantibodies
  • Normoglycemia (no impaired glucose tolerance or impaired fasting glucose)
  • Presymptomatic 1

Stage 2

  • Presence of two or more islet autoantibodies
  • Dysglycemia: impaired fasting glucose (FPG 100-125 mg/dL) and/or impaired glucose tolerance (2-h PG 140-199 mg/dL)
  • HbA1c 5.7-6.4% or ≥10% increase in HbA1c
  • Presymptomatic 1

Stage 3

  • Symptomatic disease with overt hyperglycemia
  • Diabetes by standard criteria
  • Autoantibodies may become absent at this stage 1

Clinical Presentation

Classic symptoms of type 1 diabetes include:

  • Polyuria (excessive urination)
  • Polydipsia (excessive thirst)
  • Weight loss
  • Polyphagia (excessive hunger)
  • Fatigue
  • Blurred vision 1

These symptoms typically occur for several days to a few weeks prior to diagnosis 1.

Special Considerations

In Children and Adolescents

  • For OGTT in children, a glucose load of 1.75 g/kg (maximum 75 g) should be used 1
  • Incidental hyperglycemia without classic symptoms does not necessarily indicate new-onset diabetes, especially in young children with acute illness who may experience "stress hyperglycemia" 1

Autoantibody Testing

  • Islet autoantibody tests should be performed only in an accredited laboratory with established quality control 2
  • Multiple positive autoantibodies indicate higher risk of progression to insulin dependence 2

C-peptide Testing

  • Useful in insulin-treated patients to assess residual β-cell function
  • Should not be performed within 2 weeks of a hyperglycemic emergency as results may be misleading 2, 3

Common Pitfalls to Avoid

  • Do not rely solely on A1C for diagnosis in conditions with altered relationship between A1C and glycemia (hemoglobinopathies, anemia) 1, 2
  • Point-of-care A1C assays should not be used for diagnosis unless FDA-cleared specifically for diagnostic purposes 1, 2
  • Be aware that 5-10% of adult-onset type 1 diabetes may be autoantibody negative 2
  • The metabolic state of untreated children with type 1 diabetes can deteriorate rapidly, so a definitive diagnosis should be made immediately to avoid delays in treatment 1
  • Screening for type 1 diabetes in asymptomatic children with autoantibody panels is currently recommended only in research settings or for first-degree family members of a person with type 1 diabetes 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing Type 1 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Testing of Type 1 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.